Welcome to our dedicated page for My Size SEC filings (Ticker: MYSZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
My Size, Inc. filings document the public-company reporting record for a Nasdaq-listed fashion technology and commerce issuer. The company’s Form 8-K filings report operating results, preliminary financial information, Regulation FD communications, shareholder letters and Nasdaq listing-compliance notices related to its common stock.
Proxy and annual-meeting filings cover board elections, equity incentive plan amendments, share-reserve provisions, auditor ratification and stockholder voting results. The filing record also includes late-filing notices for periodic reports, together with exhibits and Inline XBRL cover-page data that support the company’s formal disclosure of results, governance matters, capital structure and reporting status.
My Size, Inc. reported an insider equity grant to director Oron Branitzky. On December 15, 2025, he received 15,000 shares of common stock as restricted shares under the My Size, Inc. 2017 Equity Incentive Plan at a stated price of $0 per share. Following this award, he beneficially owns 17,500 common shares directly.
The restricted shares are scheduled to vest on December 31, 2025, provided Branitzky continues to serve the company through that date. This filing reflects equity-based compensation rather than an open-market purchase or sale.
My Size, Inc. reported that its Chief Financial Officer received a new equity award. On December 15, 2025, the CFO acquired 30,000 shares of common stock as restricted stock under the company’s 2017 Equity Incentive Plan at a stated price of $0 per share. Following this grant, the officer beneficially owns 32,500 shares directly.
The restricted shares vest in three equal annual installments, with one-third vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, as long as the officer continues to serve the company through each vesting date.
My Size, Inc. reported that Chief Growth Officer Borja Cembrero received an award of 110,000 shares of common stock as restricted stock on December 15, 2025 under the company’s 2017 Equity Incentive Plan. The shares were acquired at a stated price of $0, and his beneficial ownership after the grant is 117,965 shares, held directly.
Of the award, 10,000 restricted shares vest immediately, while 40,000 restricted shares vest in three equal annual installments on January 1, 2026, 2027, and 2028, subject to continued service. Up to 60,000 additional restricted shares may vest if specified profit and business targets in the restricted stock agreement are achieved and Cembrero remains in service through the applicable vesting dates.
My Size, Inc. reported that a director received a grant of restricted common stock. On 12/15/2025, the director acquired 15,000 shares of My Size common stock at a stated price of $0 per share under the company’s 2017 Equity Incentive Plan. Following this grant, the director beneficially owns 17,500 shares of common stock in direct ownership form.
The filing explains that these 15,000 restricted shares will vest on December 31, 2025, provided the director continues to serve the company through that vesting date.
My Size, Inc. executive Billy Pardo, the company’s CPO and COO, reported receiving restricted common stock awards on December 15, 2025 under the My Size, Inc. 2017 Equity Incentive Plan. He acquired 60,000 restricted shares at a price of $0, bringing his direct beneficial ownership to 79,750 shares.
In addition, Pardo reports indirect beneficial ownership of 215,000 restricted shares held by his spouse, director and CEO Ronen Luzon, increasing indirect holdings to 289,335 shares. Portions of these awards vest annually on January 1, 2026, 2027 and 2028, with other tranches tied to profit and business targets and a separate block vesting on December 31, 2025, all contingent on continued service.
My Size, Inc. director Roy Golan reported an equity award from the company. On 12/15/2025, he was granted 15,000 shares of common stock at a price of $0, reported as an acquisition of securities. Following this grant, he beneficially owns 15,000 shares, held directly.
The filing explains that these are restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. The restricted shares are scheduled to vest on December 31, 2025, and vesting is conditioned on Golan’s continued service to My Size, Inc. as of that vesting date.
My Size, Inc. director Arik Kaufman received 15,000 restricted shares of common stock on December 15, 2025. The shares were granted at a price of $0 under the My Size, Inc. 2017 Equity Incentive Plan as part of his director compensation.
These restricted shares are scheduled to vest on December 31, 2025, provided he continues to serve the company through that date. Following this grant, Kaufman beneficially owns 17,500 shares of My Size, Inc. common stock in direct ownership.
My Size, Inc. (MYSZ) reported insider share purchases by its Chief Executive Officer and director, Ronen Luzon. On 11/24/2025, he purchased 235 shares of common stock in an open-market transaction at a weighted average price of $0.885 per share, with individual trade prices ranging from $0.88 to $0.89.
On 11/25/2025, he purchased an additional 14,000 shares of common stock at a weighted average price of $0.895 per share, with trade prices ranging from $0.83 to $0.96. Following these transactions, Luzon directly beneficially owns 71,735 shares of My Size common stock.
My Size, Inc. (MYSZ) reported insider share purchases by its CEO and director Ronen Luzon. On 11/20/2025 he bought 10,500 shares of common stock at $0.76 per share and another 3,000 shares at $0.77 per share in open-market transactions.
Following these purchases, he directly owns 57,500 shares of My Size common stock. The filing reports no derivative security transactions.
My Size, Inc. (MYSZ) furnished third‑quarter results. The company reported that it issued a press release covering its results of operations for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to this Form 8‑K.
The company noted the information under Item 2.02, including Exhibit 99.1, is being furnished and not deemed filed under the Exchange Act or incorporated by reference under the Securities Act except as expressly stated.